NorthAvenue LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
NorthAvenue LLC's AMGN Position: Q3 2026 in Review
NorthAvenue LLC held its Amgen (AMGN) position steady in Q3 2026 at 2 shares worth $844. The position accounts for ﹤0.01% of the portfolio, ranked #207.
NorthAvenue LLC first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- NorthAvenue LLC held 2 shares of Amgen worth $844 as of Q3 2026.
- NorthAvenue LLC left its Amgen share count unchanged in Q3 2026.
- Amgen made up ﹤0.01% of NorthAvenue LLC's portfolio in Q3 2026, its #207 holding.
- NorthAvenue LLC first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
- 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on NorthAvenue LLC's 13F filing for Q3 2026, filed 29 Oct 2026.